Department of Neurology, University of Ulm, Ulm, Germany.
Cell Death Differ. 2012 May;19(5):847-58. doi: 10.1038/cdd.2011.165. Epub 2011 Nov 18.
Selecting neuronal cell lines for resistance against oxidative stress might recapitulate some adaptive processes in neurodegenerative diseases where oxidative stress is involved like Parkinson's disease. We recently reported that in hippocampal HT22 cells selected for resistance against oxidative glutamate toxicity, the cystine/glutamate antiporter system x(c)(-), which imports cystine for synthesis of the antioxidant glutathione, and its specific subunit, xCT, are upregulated. (Lewerenz et al., J Neurochem 98(3):916-25). Here, we show that in these glutamate-resistant HT22 cells upregulation of xCT mediates glutamate resistance, and xCT expression is induced by upregulation of the transcription factor ATF4. The mechanism of ATF4 upregulation consists of a 13 bp deletion in the upstream open reading frame (uORF2) overlapping the ATF4 open reading frame. The resulting uORF2-ATF4 fusion protein is efficiently translated even at a low phosphorylation levels of the translation initiation factor eIF2α, a condition under which ATF4 translation is normally suppressed. A similar ATF4 mutation associated with prominent upregulation of xCT expression was identified in PC12 cells selected for resistance against amyloid β-peptide. Our data indicate that ATF4 has a central role in regulating xCT expression and resistance against oxidative stress. ATF4 mutations might have broader significance as upregulation of xCT is found in tumor cells and associated with anticancer drug resistance.
选择对氧化应激具有抗性的神经元细胞系可能会重现一些涉及氧化应激的神经退行性疾病中的适应性过程,如帕金森病。我们最近报道,在海马 HT22 细胞中选择对氧化谷氨酸毒性具有抗性时,胱氨酸/谷氨酸反向转运蛋白系统 x(c)(-)会被上调,该系统将胱氨酸导入细胞以合成抗氧化剂谷胱甘肽,其特定亚基 xCT 也是如此。(Lewerenz 等人,J Neurochem 98(3):916-25)。在这里,我们表明,在这些谷氨酸抗性 HT22 细胞中,xCT 的上调介导了谷氨酸抗性,并且 xCT 表达是由转录因子 ATF4 的上调诱导的。ATF4 上调的机制包括在重叠 ATF4 开放阅读框的上游开放阅读框 (uORF2) 中缺失 13 个碱基对。由此产生的 uORF2-ATF4 融合蛋白即使在翻译起始因子 eIF2α 的低磷酸化水平下也能有效地翻译,而在这种情况下,ATF4 翻译通常受到抑制。在对淀粉样β肽具有抗性的 PC12 细胞中,发现了与 xCT 表达明显上调相关的类似 ATF4 突变。我们的数据表明,ATF4 在调节 xCT 表达和抵抗氧化应激方面具有核心作用。ATF4 突变可能具有更广泛的意义,因为 xCT 的上调在肿瘤细胞中被发现,并与抗癌药物耐药性相关。